Feb 12, 2014
Global itraconazole market: Latest market analysis presented
Current therapies consist of generics that offer substantial efficacy but sub-par safety profiles.
Tue Feb 11, 2014
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Purpose Itraconazole, a US Food and Drug Administration-approved antifungal drug, inhibits the Hedgehog signaling pathway, a crucial driver of basal cell carcinoma tumorigenesis, and reduces BCC growth in mice.
Fri Feb 07, 2014
Anti-fungal Drug Shown To Treat Cancer
Cancer has been one of the most profitable sectors for the drug industry: however, costs are rising for both the drug developers and consumers.
Mon Feb 03, 2014
Antifungal drug may treat common skin cancer, study finds
An inexpensive antifungal pill that's already on the market may help treat a very common type of skin cancer, researchers reported Monday.